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A comparison of exposure to carcinogens among roll-your-own 
and factory-made cigarette smokers 
Lion Shahab, Robert West, Ann McNeill 
ABSTRACT 
Consumption of roll-your-own (RYO) tobacco is rising but little is known about its in vivo 
delivery of toxins relative to factory made (FM) cigarettes. To start to address this issue, 
this study compared the concentrations of metabolites of recognised human carcinogens 
in smokers of RYO tobacco and FM cigarettes. We opportunistically recruited 127 FM 
and 28 RYO smokers in central London and collected saliva and urine samples. Saliva 
samples were assayed for cotinine and urinary samples for 1-HOP and Total NNAL, 
metabolic markers of polycyclic aromatic hydrocarbons and tobacco-specific N-
nitrosamines, respectively. Data on socio-demographic, anthropometric and puffing 
characteristics were also obtained. Both univariate and multivariate analyses (controlling 
for age, sex, body mass index, puff flow, puff duration and cotinine) showed no 
difference in metabolic markers between RYO and FM cigarette smokers. However, 
significant main effects for cotinine levels and sex were observed in multivariate 
analyses. Greater levels of cotinine were associated with a greater concentration of both 
1-HOP (B=0.002, p=0.037) and NNAL (B=0.002, p<0.001). In addition, women had 
significantly greater concentrations of urinary 1-HOP (B=0.679, p=0.004) and Total 
NNAL metabolites (B=0.117, p=0.024) than men, irrespective of the type of cigarettes 
smoked. More research is now needed to confirm these findings and gender-specific 
effects in a larger, representative sample. However, results do not support the common 
belief that roll-your-own cigarettes are less harmful than manufactured cigarettes. 
Key words: Total NNAL; 1-HOP; tobacco carcinogens; sex-difference; roll-your-own 
cigarettes; factory-made cigarettes 
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INTRODUCTION 
Consumption of roll-your-own (RYO) tobacco is on the increase in many countries 
including the US, UK, Australia, France and Norway (Connolly and Alpert, 2008;Oddoux 
and Melihan-Cheinin, 2001;Scollo and Borland, 2004;Kraft et al., 1998). This appears to 
be a response to tax increases of factory-made (FM) cigarettes as smokers switch to 
cheaper (often smuggled) products such as RYO tobacco (Gunby, 1994), especially 
among the most economically disadvantaged smokers (Young et al., 2006; Young et al. 
2008). Yet, despite this increase in the prevalence of RYO use, relatively little is known 
about the health impact of RYO cigarettes. 
 
The question naturally arises as to whether smoking RYO tobacco is less harmful, as 
harmful as, or more harmful than smoking FM cigarettes. Some studies suggest that 
compared with FM cigarettes, RYO cigarettes yield similar or even higher levels of toxins 
in smoke (Appel et al., 1990;Kaiserman and Rickert, 1992a;Kaiserman and Rickert, 
1992b;Darrall and Figgins, 1998). Moreover, smokers of RYO and FM cigarettes suffer 
from the same smoking-related diseases (De et al., 1992) and RYO smokers may be at 
increased risk of particular cancers (e.g. lung cancer) compared with FM cigarette 
smokers (Engeland et al., 1996;Tuyns and Esteve, 1983). 
 
To our knowledge, however, no studies thus far have examined in vivo exposure to 
recognised human carcinogens in smokers of RYO tobacco compared with FM 
cigarettes. There are many challenges to doing this in a way that would be widely 
generalisable because of potential confounders. This study is a first attempt to obtain a 
broad indication of the relative exposure of smokers of RYO tobacco to carcinogens 
compared with smokers of FM cigarettes. We chose to characterise the concentrations 
of two metabolites of known tobacco carcinogens (1-hydroxypyrene [1-HOP] and Total 
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4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol [NNAL]) in an opportunistic sample of FM 
and RYO smokers and to examine their socio-demographic correlates. We chose 1-HOP 
and Total NNAL as they are established metabolic markers of polycyclic aromatic 
hydrocarbons and tobacco specific N-nitrosamines (Hecht, 2002), which represent two 
groups of human carcinogens that are thought to play a major role in tobacco-related 
carcinogenesis (Hoffmann et al., 1997). 
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MATERIAL AND METHODS 
Participants 
The study methodology has been detailed elsewhere (Shahab et al., 2008). Briefly, FM 
and RYO cigarette smokers were opportunistically recruited through advertisements in 
local newspapers, flyers, emails, or posters on public bulletin boards at or around 
University College London. Participants had to be regular smokers (5 ≥cigarettes/day) of 
a particular brand of manufactured cigarettes or rolling tobacco for the last 3 months; be 
between 18 and 60 years of age and not be pregnant or have heart or lung disease. A 
power calculation (Faul and Erdfelder, 1992) indicated that a sample of 130 FM cigarette 
smokers and 42 RYO smokers would be required to detect a medium effect size in two-
tailed analysis. Due to time limitations and difficulty in recruiting RYO cigarette smokers 
and the exclusion of five participants because of violation of the study protocol and 
malfunctioning of machinery, the final sample was comprised of 127 FM and 28 RYO 
cigarette smokers, which reduced the power to detect only medium-to-large (Cohen’s 
d=0.6) effects. Participant characteristics are provided in Table 1. There were no 
differences in any of the baseline variables between included and excluded participants. 
 
Procedure 
Smokers visited the laboratory on two occasions, 24 hours apart. At the first visit, 
participants’ consent was obtained as well as a saliva sample and a baseline 
questionnaire assessing socio-demographic, anthropometric (height and weight) and 
smoking characteristics. Participants were asked to smoke cigarettes over the 24 hour 
period between visits with a topography device measuring puffing behaviour (complete 
results reported elsewhere, see Shahab et al., 2008). At the second visit, participants 
provided saliva and urine samples. The study received approval from University College 
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London Ethics Committee (Ref 0474/001) to confirm adherence to EU ethical research 
standards. 
 
Measures 
Biomarkers 
Saliva samples were collected with a dental roll that participants were asked to keep in 
their mouth until saturated. Saliva was assayed for cotinine, a measure of nicotine 
intake, using a validated method involving capillary column gas-liquid chromatography 
(Feyerabend and Russell, 1990). Urine was collected by participants on site in a 
sterilised sealable cup and assayed for the presence of metabolites of two common 
tobacco carcinogens, 1-HOP and Total NNAL, to determine the uptake of such 
carcinogens in smokers. 1-HOP is a metabolite of pyrene, which is always present in 
mixtures of polycyclic aromatic hydrocarbons (PAH), and therefore an accepted 
biomarker of carcinogenic hydrocarbons such as benzo(a)pyrene (Jongeneelen, 2001). 
NNAL and its glucuronides are metablites of the known lung carcinogen 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific N nitrosamine 
(Hecht, 2002). Samples were tested for 1-HOP and Total NNAL (NNAL plus NNAL-gluc) 
concentrations using high-performance liquid chromatography with fluorescence 
detection (see Carmella et al., 2004) and gas chromatography with chemiluminescence 
detection (see Hecht et al., 2006), respectively. In addition, urine was assayed for 
creatinine (using Vitros CREA slides) to correct for variable urine flow rates in metabolite 
analysis. 
 
Puffing behaviour 
Puffing behaviour was measured using the CReSSmicro® machine, a validated battery-
operated, hand-held portable device that provides data on puffing intensity including puff 
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duration and puff flow (Lee et al., 2003; Shahab et al., 2008). It uses an orifice flow 
meter mouthpiece that produces a pressure drop related to the flow rate of smoke 
through the mouthpiece. Smokers insert a cigarette in the device, smoke the cigarette as 
normal and, when finished, withdraw the cigarette butt from the device. The 
CReSSmicro® stores smoking topography data that are later downloaded for analysis. 
Recorded data were checked for consistency, invalid data removed and average values 
of puff duration and puff flow across all cigarettes smoked over 24 hours computed.  
 
Demographic and smoking characteristics 
The baseline questionnaire assessed participants’ cigarette consumption, smoking 
history and quit plans, as well as general demographic information. Smokers of RYO 
tobacco were also asked to indicate whether they used filters when rolling cigarettes. 
Deprivation level was determined using the Index of Multiple Deprivation (IMD), a 
reliable measure of relative poverty based on post codes (Jordan et al., 2004) and 
participants’ self-reported height and weight were used to calculate the body mass index 
(BMI in kg/m2). 
 
Analysis 
Data were analysed with SPSS 16.0. Group differences in baseline variables were 
assessed with the chi-square test for dichotomous data, and t-test for continuous 
variables. As the distribution of metabolite concentrations was positively skewed and 
showed significant heteroscedasticity between FM and RYO cigarette smokers, a 
general linear model (GLM) with a gamma distribution and robust estimates was fitted to 
determine group differences in Total NNAL and 1-HOP. In order to control for possible 
confounders, socio-demographic variables, puffing behaviour and cotinine as well as 
interaction terms were entered as covariates in the GLM.
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RESULTS 
Smokers of hand-rolling tobacco were more likely to be male (χ2(1)=6.6, p=.01), 
consumed more cigarettes (t(153)=2.3, p=0.022) and, while not significant, had 
somewhat higher baseline cotinine levels. There were no other differences in terms of 
socio-demographic or smoking characteristics between RYO and FM cigarette smokers 
(Table 1). 
 
Table 1 about here 
 
Table 2 provides the concentrations of the creatinine-adjusted carcinogen metabolites 
for smokers of hand-rolling tobacco and manufactured cigarettes. Whilst 1-HOP levels 
were somewhat higher in RYO than FM cigarette smokers, no significant differences in 
1-HOP or Total NNAL concentrations were detected between smokers of either type of 
cigarette. 
 
Table 2 about here 
 
Nearly two thirds of RYO smokers (N=18) used a filter for rolling cigarettes while the 
remaining third used either a roach (piece of card board) or nothing. There were no 
differences in urinary metabolites among RYO smokers or between FM and RYO 
smokers as function of filter use. However, 1-HOP levels were somewhat elevated 
among RYO smokers using a filter as compared with those not using a filter (Table 2). 
 
As this sample was not randomly sampled, we used a general linear model to control for 
putative behavioural and biological confounders that may influence carcinogen exposure 
and metabolism. The model adjusted for socio-demographic and anthropometric factors 
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(age, sex, body mass index) as well as a biomarker of nicotine intake (cotinine). As a 
previous study indicated that RYO compared with FM cigarettes smokers puff cigarettes 
less hard but for longer (Shahab et al, 2008), markers of puffing intensity (puff flow and 
puff duration) were also included in this model. Lastly, while cotinine levels significantly 
increased from baseline to follow-up (t(154)=4.3, p<0.001), there was no significant 
change in model estimates if either baseline or follow-up cotinine levels were entered 
and average cotinine values are therefore used in the analysis. Table 3 provides the final 
model. 
 
Table 3 about here 
 
Confirming the univariate analysis, results suggest that there was no effect of the type of 
cigarette smoked on creatinine-adjusted 1-HOP and Total NNAL concentrations. 
However, cotinine level had a significant association with 1-HOP and Total NNAL 
concentrations; higher cotinine concentrations were associated with a greater urinary 
concentration of carcinogen metabolites. In addition, there was a main effect of sex on 1-
HOP and Total NNAL levels. As men were more likely than women to smoke RYO 
cigarettes, we included a cigarette type by sex interaction term in the GLM to explore this 
further. No significant interaction was observed for either 1-HOP or Total NNAL levels. 
 
As shown in Figures 1 and 2, for both men and women there was a tendency towards 
higher 1-HOP concentrations among smokers of RYO tobacco than FM cigarettes but 
virtually identical levels of Total NNAL. Moreover, irrespective of the cigarette type 
smoked and the metabolite that was assessed, concentrations, and thus likely 
carcinogenic exposure, were greater among women than men. 
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Figures 1 and 2 about here 
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DISCUSSION 
This is the first study comparing carcinogen metabolites in vivo in smokers of RYO and 
FM cigarettes. Our data suggest a similar intake of the carcinogens concerned. The 
relatively greater level of 1-HOP but not Total NNAL in RYO smokers may be due to a 
combination of behavioural factors and product design differences; smokers of hand-
rolling tobacco are more likely to relight their cigarette (thus increasing the level of 
combustion-related carcinogens such as benzo(a)pyrene) and RYO cigarettes tend to 
have inferior filtering to FM cigarettes. Indeed, the use of filters by RYO smokers if 
anything appeared to increase 1-HOP levels compared with the levels in smokers of 
unfiltered RYO cigarettes. Moreover, as RYO smokers in contrast to smokers of 
manufactured cigarettes can manipulate the physical characteristics of their cigarettes, 
they are potentially exposed to a wider range of carcinogen yields than FM cigarette 
smokers (Kaiserman and Rickert, 1992b). 
 
There was a marked sex difference in carcinogen metabolites; women had higher 
concentrations of 1-HOP and Total NNAL than men irrespective of the cigarette type 
smoked. This result is consistent with studies reporting that women may be at greater 
risk to develop lung cancer than men when controlling for consumption (Zang and 
Wynder, 1996;Kreuzer et al., 2000;Henschke and Miettinen, 2004;but see Bain et al., 
2004). Moreover, in agreement with the results reported here, it has been suggested that 
women have a greater expression of particular polymorphisms in genes that are likely to 
be involved in metabolising tobacco-related carcinogens (CYP1A1 and GSTM1) leading 
to increased lung cancer susceptibility (e.g. Dresler et al., 2000;Mollerup et al., 2006). 
 
The study has a number of limitations. The sample was self-selected and relatively 
small, particularly the pool of RYO smokers. However, the socio-demographic profile of 
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RYO smokers was relatively similar to that of RYO smokers in the population as shown 
by a greater number of men than women smoking RYO tobacco (Goddard, 2006), 78.6% 
of RYO smokers in our sample were male. We did not measure in vivo tobacco 
carcinogen levels directly but rather assessed metabolites of carcinogens. Yet, these 
metabolites are generally considered to be reliable biomarkers of carcinogen exposure 
and are therefore unlikely to have biased results (Hecht, 2002). Lastly, considering that 
tobacco smoke is thought to contain around 60 human carcinogens (International 
Agency for Research on Cancer, 2004), this study does not allow us to make any 
statements as to whether RYO and FM or male and female smokers are exposed to 
different levels of carcinogen in toto. However, we purposefully selected biomarkers of 
those carcinogens (PAH and TSNA) that count among the best characterized of all 
tobacco carcinogens and are likely to play a major role in the development of smoking-
related cancers (Hecht, 1999). Moreover, the fact that observed sex-differences were 
found for the metabolites of both these groups of carcinogens would confer some degree 
of generalisability of this finding to other tobacco-related carcinogens. 
 
While there is some variation from country to country (Young et al., 2008), many 
smokers tend to think that RYO cigarettes are more ‘natural’ and therefore may confer 
some health benefit over FM cigarettes (O'Connor et al., 2007;Young et al., 2006). Our 
results suggest that this is not the case. This finding highlights that greater health 
education efforts are needed to make smokers of all tobacco products, including hand-
rolled cigarettes, aware that there is no completely safe alternative to smoking cessation. 
Very little is currently known as to why women may have a greater risk to develop 
smoking-related diseases, and more research is now needed to confirm findings 
reported here and expand our knowledge of the impact of increasingly popular RYO 
cigarettes on carcinogenic exposure and ultimately health.
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Tables 
Table 1: Baseline socio-demographic and smoking characteristics 
 All smokers 
(N=155) 
 
 
FM 
(N=127) 
RYO 
(N=28) 
Demographic data     
   Mean (SD) age 31.8 (10.9)  31.4 (10.5) 33.4 (12.3) 
   Percent (N) male 56.8    (88)  52.0    (66) 78.6    (22)* 
   Mean (SD) IMD 31.7 (13.1)  31.9 (13.4) 30.4 (11.6) 
   Mean (SD) BMI 24.0   (4.0)  24.1   (4.1) 23.3   (3.5) 
Smoking data     
   Mean (SD) cigarettes 
   per day  
13.9   (5.9)  13.4   (5.7) 16.1   (6.4)* 
   Mean (SD) length of 
   time of smoking in years 
14.5 (11.2)  14.1 (10.8) 16.2 (12.9) 
   Percent (N) smoking  
   marijuana 
36.8    (57)  36.2    (46) 39.3    (11) 
   Percent (N) Want to 
   quit next month 
10.3    (16)  11.0   (14)   7.1      (2) 
   Mean (SD) Baseline  
   Salivary Cotinine (ng/ml) 
272   (154)  265   (153) 305   (158) 
IMD: Index of multiple deprivation; BMI: Body-mass index; *p<0.05 
 
Table 2: Level of carcinogen metabolites by cigarette type 
 
Table 3: General Linear Model for carcinogen metabolites controlling for confounders 
 1-HOP  Total NNAL 
 B 95%CI p  B 95%CI p 
Cigarette type*  0.530 -0.739 – 1.800 0.413  -0.008 -0.120 – 0.104 0.892 
Sex^  0.679  0.214 – 1.145 0.004   0.117  0.015 – 0.219 0.024 
BMI -0.030 -0.085 – 0.026 0.294  -0.001 -0.011 – 0.009 0.807 
Age  0.000 -0.019 – 0.019 0.986   0.005 -0.002 – 0.011 0.162 
Puff flow -0.030 -0.067 – 0.007 0.107  -0.003 -0.010 – 0.004 0.445 
Puff duration  0.000 -0.001 – 0.000 0.148   0.000  0.000 – 0.000 0.579 
Cotinine  0.002  0.000 – 0.003 0.037   0.002  0.001 – 0.002 <0.001 
*Reference category: factory-made cigarettes; ^Reference category: men; BMI: Body-mass index 
 
All smokers 
(N=155) 
Factory 
made 
(N=127) 
Roll-Your-Own 
Total 
(N=28) 
Filter 
(N=18) 
No Filter 
(N=10) 
Carcinogen 
metabolites 
Mean (S.D.) in pmol/mg creatinine 
1-HOP 1.58 (1.61) 1.46 (1.25) 2.10 (2.69) 
2.36 
(3.05) 
1.62 
(1.95) 
Total NNAL 0.60 (0.45) 0.62 (0.47) 0.53 (0.32) 
0.50 
(0.36) 
0.58 
(0.22) 
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Figure Legend 
 
Figure 1: ^Estimated marginal means adjusted for covariates (age, body mass index, 
puff flow, puff duration, cotinine); 1-HOP – 1-hydroxypyrene; FM – Factory-made; RYO 
– Roll-your-own; Error bars indicate 95% confidence interval of the mean 
 
Figure 2: ^Estimated marginal means adjusted for covariates (age, body mass index, 
puff flow, puff duration, cotinine); Total NNAL – 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanol; FM – Factory-made; RYO – Roll-your-own; Error bars indicate 95% confidence 
interval of the mean 
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Figure 1: 1-HOP levels in men and women by cigarette type 
 
 
Figure 2: Total NNAL levels in men and women by cigarette type 
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